Quadria Capital’s Amit Varma and Sunil Thakur outline the firm’s healthcare investment strategy after the Nephroplus listing, highlighting focus areas such as med-tech, outsourcing, CRDMOs and long-term exits through strategic sales.
Quadria Capital’s Amit Varma and Sunil Thakur outline the firm’s healthcare investment strategy after the Nephroplus listing, highlighting focus areas such as med-tech, outsourcing, CRDMOs and long-term exits through strategic sales.